Referenties magma 3/2008 Casuïstiek

Dovnload 5.44 Kb.

Referenties magma 3/2008 Casuïstiek

Grootte5.44 Kb.

Dovnload 5.44 Kb.

Referenties MAGMA 3/2008


(1) Ruggenenti P, Remuzzi A, Ondei P et al. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int 2005;68(1):206‑16.

(2) Masyuk TV, Masyuk AI, Torres VE et al. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'‑cyclic monophosphate. Gastroenterology 2007;132(3):1104-16.

(3) Keimpema L van, de Koning DB, Strijk SP et al. Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts. Dig Dis Sci 2008;In Press.

(4) Keimpema L van, Ruurda JP, Ernst MF et al. Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%. J Gastrointest Surg 2008;12(3):477-82.

(5) Kalambokis G, Economou M, Kosta P et al. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites. J Clin Gastroenterol 2006;40(4):342-6.

 Helicobacter pylori: een biopt bij iedere gastroscopie?

  1. Ford AC, Forman,Bailey AG, Axon ATR, Moayyedi P. A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial. Gastroenterology 2005;129:1910-7.

  2. Talley JN, Fock KM, Moayyedi P. Gastric cancer consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high risk populations to prevent gastric cancer. Am J Gastroenterol 2008;103:510-4.

  •  Helicobacter pylori: een biopt bij iedere gastroscopie

  • Dovnload 5.44 Kb.